During the past decade, Iwate Prefectural Central Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iwate Prefectural Central Hospital" #1 sponsor was "Bayer" with 4 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Chugai Pharmaceutical" with 1 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iwate Prefectural Central Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Iwate Prefectural Central Hospital" are "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Acute Ischemic Stroke" (1 trials), "Atopic Dermatitis" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Iwate Prefectural Central Hospital" in a lesser frequency.

Most popular intervention types in "Iwate Prefectural Central Hospital" are "Drug" (10 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Finerenone (BAY94-8862)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Iwate Prefectural Central Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Iwate Prefectural Central Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Iwate Prefectural Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Iwate Prefectural Central Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".